---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-25-000024"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T14:54:11.468590+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q1 revenue surges 214% to $211.8M; net income $14.6M vs loss $0.4M

## Summary
- Diluted EPS $2.56 vs ($0.08) in Q1 2024; EBITDA $43.1M (+507% YoY).
- Arbitration process added ~$105M in revenue, 73% of total revenue increase.
- Stock-based compensation $36.1M (non-cash, one-time) weighed on GAAP net income.
- Cash from operations $51.0M; cash balance $87.7M, long-term debt $21.7M.
- Hospital visits up 20.5% YoY; mature hospitals revenue rose 186.5%.

## SEC filing metadata
- accession: 0001479681-25-000024
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000024/0001479681-25-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000024/nutx-20250513x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-25-000024
- JSON: https://secwatch.observer/filing/0001479681-25-000024.json
- Plain text: https://secwatch.observer/filing/0001479681-25-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.